A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719

Condition:   Head and Neck Squamous Cell Cancer
Intervention:   Drug: BYL719
Sponsor:   Lawson Health Research Institute
Not yet recruiting - verified April 2017

http://ift.tt/2pYksH4